194 related articles for article (PubMed ID: 22529167)
1. Perspectives of patients, family caregivers and physicians about the use of opioids for refractory dyspnea in advanced chronic obstructive pulmonary disease.
Rocker G; Young J; Donahue M; Farquhar M; Simpson C
CMAJ; 2012 Jun; 184(9):E497-504. PubMed ID: 22529167
[TBL] [Abstract][Full Text] [Related]
2. Using opioids to treat dyspnea in advanced COPD: attitudes and experiences of family physicians and respiratory therapists.
Young J; Donahue M; Farquhar M; Simpson C; Rocker G
Can Fam Physician; 2012 Jul; 58(7):e401-7. PubMed ID: 22798476
[TBL] [Abstract][Full Text] [Related]
3. Attitudes toward opioids for refractory dyspnea in COPD among Dutch chest physicians.
Janssen DJ; de Hosson SM; bij de Vaate E; Mooren KJ; Baas AA
Chron Respir Dis; 2015 May; 12(2):85-92. PubMed ID: 25676931
[TBL] [Abstract][Full Text] [Related]
4. Junior doctors' attitudes to opioids for refractory breathlessness in patients with advanced chronic obstructive pulmonary disease.
Smallwood N; Gaffney N; Gorelik A; Irving L; Le B; Philip J
Intern Med J; 2017 Sep; 47(9):1050-1056. PubMed ID: 28585274
[TBL] [Abstract][Full Text] [Related]
5. Opioids in patients with COPD and refractory dyspnea: literature review and design of a multicenter double blind study of low dosed morphine and fentanyl (MoreFoRCOPD).
van Dijk M; Mooren KJM; van den Berg JK; van Beurden-Moeskops WJC; Heller-Baan R; de Hosson SM; Lam-Wong WY; Peters L; Pool K; Kerstjens HAM
BMC Pulm Med; 2021 Sep; 21(1):289. PubMed ID: 34507574
[TBL] [Abstract][Full Text] [Related]
6. Palliation of dyspnoea in advanced COPD: revisiting a role for opioids.
Rocker G; Horton R; Currow D; Goodridge D; Young J; Booth S
Thorax; 2009 Oct; 64(10):910-5. PubMed ID: 19786716
[TBL] [Abstract][Full Text] [Related]
7. Chronic breathlessness in advanced cardiorespiratory disease: patient perceptions of opioid use.
Moran T; Zentner D; Wong J; Philip J; Smallwood N
BMJ Support Palliat Care; 2023 Dec; 13(e2):e334-e343. PubMed ID: 33837113
[TBL] [Abstract][Full Text] [Related]
8. Perspectives of pain specialists, patients, and family members on long-term opioid use for chronic non-cancer pain: a qualitative study.
Seangrung R; Tempeetikul T; Pannarunothai S; Sakdanuwatwong S
BMC Anesthesiol; 2021 Nov; 21(1):275. PubMed ID: 34753421
[TBL] [Abstract][Full Text] [Related]
9. [Refractory Dyspnea in Advanced COPD: Palliative Treatment with Opioids].
Ficker JH; Brückl WM
Pneumologie; 2019 Jul; 73(7):430-438. PubMed ID: 31291670
[TBL] [Abstract][Full Text] [Related]
10. Barriers to Prescribing Opioids in the Management of Chronic Breathlessness in COPD: A Review.
Keogh E; Williams EM
COPD; 2021 Dec; 18(6):713-722. PubMed ID: 34761726
[TBL] [Abstract][Full Text] [Related]
11. Opioids for palliation of refractory dyspnea in chronic obstructive pulmonary disease patients.
Varkey B
Curr Opin Pulm Med; 2010 Mar; 16(2):150-4. PubMed ID: 20071992
[TBL] [Abstract][Full Text] [Related]
12. Prescription of opioids for breathlessness in end-stage COPD: a national population-based study.
Ahmadi Z; Bernelid E; Currow DC; Ekström M
Int J Chron Obstruct Pulmon Dis; 2016; 11():2651-2657. PubMed ID: 27799763
[TBL] [Abstract][Full Text] [Related]
13. Opioid utility for dyspnea in chronic obstructive pulmonary disease: a complicated and controversial story.
Vozoris NT
Ann Palliat Med; 2020 Mar; 9(2):571-578. PubMed ID: 31865744
[TBL] [Abstract][Full Text] [Related]
14. A critical review of the respiratory benefits and harms of orally administered opioids for dyspnea management in COPD.
Vozoris NT
Expert Rev Respir Med; 2021 Dec; 15(12):1579-1587. PubMed ID: 34761704
[TBL] [Abstract][Full Text] [Related]
15. The dyspnea target: can we zero in on opioid responsiveness in advanced chronic obstructive pulmonary disease?
Horton R; Rocker G; Currow D
Curr Opin Support Palliat Care; 2010 Jun; 4(2):92-6. PubMed ID: 20443250
[TBL] [Abstract][Full Text] [Related]
16. Management of refractory breathlessness with morphine in patients with chronic obstructive pulmonary disease.
Smallwood N; Le B; Currow D; Irving L; Philip J
Intern Med J; 2015 Sep; 45(9):898-904. PubMed ID: 26332621
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and management of chronic breathlessness in COPD in a tertiary care center.
Carette H; Zysman M; Morelot-Panzini C; Perrin J; Gomez E; Guillaumot A; Burgel PR; Deslee G; Surpas P; Le Rouzic O; Perez T; Chaouat A; Roche N; Chabot F;
BMC Pulm Med; 2019 May; 19(1):95. PubMed ID: 31096982
[TBL] [Abstract][Full Text] [Related]
18. Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline.
Marciniuk DD; Goodridge D; Hernandez P; Rocker G; Balter M; Bailey P; Ford G; Bourbeau J; O'Donnell DE; Maltais F; Mularski RA; Cave AJ; Mayers I; Kennedy V; Oliver TK; Brown C;
Can Respir J; 2011; 18(2):69-78. PubMed ID: 21499589
[TBL] [Abstract][Full Text] [Related]
19. Influences of attitudes on family physicians' willingness to prescribe long-acting opioid analgesics for patients with chronic nonmalignant pain.
Nwokeji ED; Rascati KL; Brown CM; Eisenberg A
Clin Ther; 2007; 29 Suppl():2589-602. PubMed ID: 18164924
[TBL] [Abstract][Full Text] [Related]
20. Opioid therapy for refractory dyspnea in patients with advanced chronic obstructive pulmonary disease: patients' experiences and outcomes.
Rocker GM; Simpson AC; ; Horton R; Sinuff T; Demmons J; ; Hernandez P; Marciniuk D
CMAJ Open; 2013 Jan; 1(1):E27-36. PubMed ID: 25077099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
